Mónica Giraldo

Mónica Giraldo

Auto-generated profile, based on publicly available information

Mónica Giraldo

Department of Microbiology and Parasitology, Group of Primary Immunodeficiencies, University of Antioquia, Medellín 05001, Colombia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Clínica E Investigación En Ginecología Y Obstetricia
Verified
Journal Article
Closed access
ACA. Cano-Cháves
A. Cano-Cháves
SGS. Galarzo-Pardo
S. Galarzo-Pardo
Jenniffer Puerta-SuárezJenniffer Puerta-Suárez
Jenniffer Puerta-Suárez
MGM. Giraldo
M. Giraldo
ÁCÁ.P. Cadavid
Á.P. Cadavid
WMWalter D. Cardona Maya
Walter D. Cardona Maya

5 December 2020 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
LALeidy Alvarez
Leidy Alvarez
JCJavier Contreras
Javier Contreras
MGMónica Giraldo
Mónica Giraldo
Background. It is postulated that cocoa solids possess cardioprotective capacity by various mechanisms. In the different cocoa studies evaluating cardiovascular disease, there are no conclusive data on the role it plays in controlling the lipid profile and anthropometric variables, perhaps because the concentration of cocoa, the geographical origin of the population, and the different concentrations supplied lead to a high heterogeneity of results. This study aims to estimate the effect of consuming cocoa-rich chocolate compared to placebo on the lipid profile and anthropometric variables based on data from three clinical trials conducted in Colombia. Methods. Meta-analysis of individual data from three randomized clinical trials conducted in Colombia. The entire population of the primary studies was included, which was reassigned into intervention groups if they consumed 50 grams of 70 concentrated cocoa or placebo, which was considered to be cocoa-free or with a concentration less than 50 grams. The variables at the beginning of the study were analyzed with medians, interquartile ranges, means, and deviations according to whether they met the normality assumption. Multiple imputations were used to manage missing data and were analyzed using the two approaches proposed for this type of study, that of one and two stages. In the two-stage approach, the data were weighted on a conventional Forrest plot, while in the one-stage approach, linear regressions with mixed models were applied. This study is governed by the regulations described in the 2013 Declaration of Helsinki and by article 11 of Resolution 8430 of 1993, which classifies it as a risk-free study. Results. A total of 275 participants were included, who consumed cocoa or placebo for 81 days on average; 52.7 were female and few smoked at the time of the intervention (31/275). Physical activity performed in number of hours per week was comparable between the intervention groups. When evaluating total cholesterol, low-density cholesterol (LDL), high-density cholesterol (HDL), triglycerides, abdominal circumference, and final body mass index with both the one-stage and two-stage approaches, there were no significant differences between the two groups. Conclusions. According to the results obtained in the meta-analysis, the consumption of cocoa in the Colombian population does not seem to significantly modify variables such as lipid profile, abdominal circumference, and body mass index. This conclusion according to the quality of the evidence has a weak recommendation and a low-to-moderate certainty. However, the analysis through the two proposed approaches yielded similar results.

1 October 2019 in IATREIA
Verified
Journal Article
Open access
PDF file
MCMaría Camila Cardona-Ocampo
María Camila Cardona-Ocampo
MGMónica Lucía Giraldo-Restrepo
Mónica Lucía Giraldo-Restrepo
LALuz Ángela Angarita-Fuentes
Luz Ángela Angarita-Fuentes
CJCarlos José Jaramillo-Gómez
Carlos José Jaramillo-Gómez
PPPablo Javier Patiño-Grajales
Pablo Javier Patiño-Grajales
HGHéctor Iván García-García
Héctor Iván García-García
Adherencia declarada y calculada al consumo de chocolate en los participantes de un ensayo clínico que mide el efecto del cacao en la hipertensión arterial con diagnóstico reciente. Medellín, Colombia